Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma
Breast Cancer Research and Treatment, 04/13/2012Jabbour MN et al.
The findings support the notion of re–evaluating estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor (Her–2/neu) expression in distant metastasis, lymph node metastasis and to a lesser extent local recurrence. The effects of neoadjuvant therapy on receptor expression are more pronounced for PR, which may have a prognostic role in therapy efficacy.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.